PL2173324T3 - Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów - Google Patents

Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów

Info

Publication number
PL2173324T3
PL2173324T3 PL08827889T PL08827889T PL2173324T3 PL 2173324 T3 PL2173324 T3 PL 2173324T3 PL 08827889 T PL08827889 T PL 08827889T PL 08827889 T PL08827889 T PL 08827889T PL 2173324 T3 PL2173324 T3 PL 2173324T3
Authority
PL
Poland
Prior art keywords
arthrosis
gel
preparation
treatment
injectable compositions
Prior art date
Application number
PL08827889T
Other languages
English (en)
Inventor
Samuel Gavard Molliard
Olivier Benoit
Original Assignee
Aptissen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2173324(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aptissen Sa filed Critical Aptissen Sa
Publication of PL2173324T3 publication Critical patent/PL2173324T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PL08827889T 2007-07-02 2008-07-02 Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów PL2173324T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0704772A FR2918276B1 (fr) 2007-07-02 2007-07-02 "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
EP08827889.0A EP2173324B1 (fr) 2007-07-02 2008-07-02 Gel injectable d'acide hyaluronique pour le traitement des degenerescences articulaires
PCT/FR2008/000948 WO2009024670A2 (fr) 2007-07-02 2008-07-02 Gel injectable d ' acide hyaluronique pour le traitement des degenerescences articulaires

Publications (1)

Publication Number Publication Date
PL2173324T3 true PL2173324T3 (pl) 2019-09-30

Family

ID=39167393

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08827889T PL2173324T3 (pl) 2007-07-02 2008-07-02 Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów
PL19156054T PL3498262T3 (pl) 2007-07-02 2008-07-02 Kwas hialuronowy - żel do wstrzykiwania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL19156054T PL3498262T3 (pl) 2007-07-02 2008-07-02 Kwas hialuronowy - żel do wstrzykiwania

Country Status (14)

Country Link
US (1) US9138405B2 (pl)
EP (2) EP3498262B1 (pl)
JP (1) JP5517133B2 (pl)
KR (1) KR20100028582A (pl)
CN (2) CN101686936A (pl)
BR (1) BRPI0813011B8 (pl)
CA (1) CA2691600C (pl)
ES (2) ES2735376T3 (pl)
FR (1) FR2918276B1 (pl)
HU (1) HUE056793T2 (pl)
PL (2) PL2173324T3 (pl)
PT (2) PT2173324T (pl)
TR (1) TR201909779T4 (pl)
WO (1) WO2009024670A2 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945949B1 (fr) 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
FR2954165B1 (fr) 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
JP5457238B2 (ja) * 2010-03-17 2014-04-02 電気化学工業株式会社 ヒアルロン酸及び／又はその塩の含有液の加熱滅菌方法
IT1402382B1 (it) * 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
WO2012143876A1 (en) * 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US8623839B2 (en) * 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
GB201118586D0 (en) * 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
WO2013076162A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Formulations useful in the treatment of osteoarticular diseases
WO2013076160A1 (en) * 2011-11-21 2013-05-30 Université Libre de Bruxelles Sustained release formulations useful in the treatment of diseases
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
BR112015016734A2 (pt) * 2013-01-11 2017-07-11 Carbylan Therapeutics Inc composições estabilizadas compreendendo ácido hialurônico
ES2837626T3 (es) * 2013-07-10 2021-07-01 Matrix Biology Inst Composiciones de hialuronano con alta elasticidad y usos de las mismas
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
CN105873955B (zh) 2013-11-25 2019-03-15 杜特里亚生物材料有限责任公司 富氘透明质酸
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
FR3032617B1 (fr) * 2015-02-16 2018-03-16 Kylane Laboratoires Sa Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu
RU2020123728A (ru) 2015-09-24 2021-01-18 Матрикс Байолэджи Инститьют Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
CN105879124B (zh) * 2016-04-26 2019-03-19 华熙福瑞达生物医药有限公司 一种注射用左旋聚乳酸填充剂及其制备方法
KR101916193B1 (ko) 2016-08-25 2018-11-07 주식회사 파마리서치프로덕트 핵산 및 키토산을 포함하는 관절강 주사용 조성물
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
FR3063649B1 (fr) 2017-03-07 2021-05-21 Laboratoire De Rhumatologie Appliquee Nouvelle solution visco-elastique et son utilisation en rhumatologie
FI3672653T3 (fi) * 2017-08-22 2023-06-07 Moebius Medical Ltd Liposomiformulaatio nivelen voiteluun
IT201800007683A1 (it) 2018-07-31 2020-01-31 Altergon Sa Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
WO2020111888A1 (ko) * 2018-11-30 2020-06-04 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물
US12440835B2 (en) 2019-01-21 2025-10-14 Vias Partners, Llc Methods, systems and apparatus for separating components of a biological sample
MX2022004999A (es) 2019-10-31 2022-07-27 Eclipse Medcorp Llc Sistemas, metodos y aparatos para separar componentes de una muestra.
US11679458B2 (en) 2019-11-04 2023-06-20 Covidien Lp Devices, systems, and methods for treating aneurysms
EP3854377A1 (fr) * 2020-01-22 2021-07-28 Laboratoires Genevrier Sas Composition comprenant de l'acide hyaluronique et un polyol ou de carboxyméthylcellulose
WO2022198208A1 (en) 2021-03-16 2022-09-22 Covidien Lp Injectable biopolymer compositions and associated systems and methods
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS
WO2025133721A1 (en) * 2023-12-19 2025-06-26 Universidade Nova De Lisboa Injectable composition of nonsteroidal anti-inflammatory drugs, methods and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
AU621305B2 (en) * 1987-07-01 1992-03-12 Genentech Inc. Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
JP2788340B2 (ja) * 1989-12-21 1998-08-20 株式会社ニッショー 炎症治療剤
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
IT1291291B1 (it) * 1997-04-30 1999-01-07 Chemedica Sa Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
EP1465596A1 (en) * 2002-01-18 2004-10-13 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
WO2004073759A1 (en) 2003-02-19 2004-09-02 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050215516A1 (en) 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
WO2006067608A1 (en) * 2004-12-22 2006-06-29 Laboratoire Medidom S.A. Aqueous formulations based on sodium hyaluronate for parenteral use
FR2895907B1 (fr) * 2006-01-06 2012-06-01 Anteis Sa Gel viscoelastique a usage dermatologique
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique

Also Published As

Publication number Publication date
PL3498262T3 (pl) 2022-02-07
CA2691600C (fr) 2017-01-10
WO2009024670A3 (fr) 2009-04-23
JP2010531863A (ja) 2010-09-30
PT3498262T (pt) 2021-11-11
KR20100028582A (ko) 2010-03-12
EP3498262A1 (fr) 2019-06-19
EP3498262B1 (fr) 2021-09-01
FR2918276B1 (fr) 2010-01-22
ES2735376T3 (es) 2019-12-18
TR201909779T4 (tr) 2019-07-22
BRPI0813011A2 (pt) 2014-12-23
US20100184720A1 (en) 2010-07-22
WO2009024670A2 (fr) 2009-02-26
CN104825482A (zh) 2015-08-12
CN101686936A (zh) 2010-03-31
EP2173324A2 (fr) 2010-04-14
ES2898939T3 (es) 2022-03-09
BRPI0813011B8 (pt) 2021-05-25
JP5517133B2 (ja) 2014-06-11
HUE056793T2 (hu) 2022-03-28
CA2691600A1 (fr) 2009-02-26
US9138405B2 (en) 2015-09-22
PT2173324T (pt) 2019-07-09
FR2918276A1 (fr) 2009-01-09
BRPI0813011B1 (pt) 2019-10-08
EP2173324B1 (fr) 2019-04-10

Similar Documents

Publication Publication Date Title
PL2173324T3 (pl) Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów
ITRM20030210A1 (it) Protesi da impiegarsi nella terapia chirurgica del prolasso
PT3127551T (pt) Composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
IL212960A (en) Sulfonamide derivatives, the vehicle containing them and their use in cancer treatment
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
SMT201500176B (it) Composizioni e metodi per inibire l'espressione ditranstiretina
BR112013009142A2 (pt) "composição modeladora de fibra queratinosa, kit modelador de fibra queratinosa e métod para tratamento de uma fibra queratinosa"
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
NO20092637L (no) Fremgangsmater for behandling
SI2185581T1 (sl) Postopki in sestavki, uporabni v zdravljenju mukozitisa
SMT201600388B (it) Ligandi leganti opsina, composizioni e metodi d'uso
SI2203153T1 (sl) Uporaba nove naravne snovi v kozmetičih sestavkih
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
PL3121280T3 (pl) Antysensowne kompozycje i sposoby ich wytwarzania i stosowania
PT2099321T (pt) Composições de leite humano e métodos de fabrico e utilização das mesmas
GB0703369D0 (en) Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines
EP2058014A4 (en) ARTIFICIAL BONE ASSOCIATION
PL1827109T3 (pl) Zastosowanie naturalnych ekstraktów roślinnych w kompozycjach kosmetyków
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
LT2254869T (lt) Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška
DK3363857T3 (da) Hybride modstandsreducerende sammensætninger med højt polymerindhold
PL2501234T3 (pl) Sposoby i kompozycje stosowane w leczeniu dolegliwości związanych z zespołem stresu pourazowego z użyciem cyklobenzapryny
HRP20190045T1 (hr) Metode i sastavi za liječenje upalne bolesti crijeva
BRPI1006972A2 (pt) "dispositivo e instrumentação para facilitar a colocação de parafusos nos tecidos ósseos"
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS